Journal of Cataract & Refractive Surgery
Volume 33, Issue 7 , Pages 1227-1234 , July 2007

Intraoperative floppy-iris syndrome associated with α1-adrenoreceptors: Comparison of tamsulosin and alfuzosin

,Accepted 13 March 2007.

References 

  1. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005;31:664–673
  2. Chadha V, Borooah S, Tey A, et al. Floppy iris behaviour during cataract surgery: associations and variations. Br J Ophthalmol. 2007;91:40–42
  3. Pärssinen O. The use of tamsulosin and iris hypotony during cataract surgery. [letter] Acta Ophthalmol Scand. 2005;83:625–626
  4. Pärssinen O, Leppänen E, Keski-Rahkonen P, et al. Influence of tamsulosin on the iris and its implications for cataract surgery. Invest Ophthalmol Vis Sci. 2006;47:3766–3771
  5. Cheung CMG, Awan MAR, Sandramouli S. Prevalence and clinical findings of tamsulosin-associated intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2006;32:1336–1339
  6. Settas G, Fitt AW. Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy. [letter] Eye. 2006;20:1431–1432
  7. Parmar B, Qatarneh D, Claoué C. Alpha antagonists in cataract surgery. [letter] J Cataract Refract Surg. 2005;31:2241
  8. Nakamura S, Taniguchi T, Suzufi F, et al. Evaluation of α1-adrenoreceptors in the rabbit iris: pharmacological characterization and expression of mRNA. Br J Pharmacol. 1999;127:1367–1374
  9. Suzuki F, Taniguchi T, Nakamura S, et al. Distribution of alpha-1 adrenoreceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol. 2002;135:600–608
  10. Ishikawa H, Miller DD, Patel PN. Comparison of post-junctional α-adrenoreceptors in iris dilator muscle of humans, and albino and pigmented rabbits. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:765–772
  11. van Kerrebroeck PEV. The efficacy and safety of a new once-a-day formulation of an alpha-blocker. Eur Urol. 2001;39(suppl 6):19–26
  12. Lowe FC. Role of the newer α1-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther. 2004;26:1701–1713
  13. Mottet N, Bressolle F, Delmas V, et al. Prostatic tissual distribution of alfuzosin in patients with benign prostatic hyperplasia following repeated oral administration. Eur Urol. 2003;44:101–105
  14. Milani S, Djavan B. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on α1-adrenoreceptor antagonists. BJU Int. 2005;95(suppl 4):29–36
  15. Djavan B, Chapple C, Milani S, Marberger M. State of the art on the efficacy and tolerability of alpha1-adrenoreceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. 2004;64:1081–1088
  16. Djavan B, Marberger M. A meta-analysis on the efficacy and tolerability of α1-adrenoreceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol. 1999;36:1–13
  17. Schwinn DA, Afshari NA. α1-adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome. Surv Ophthalmol. 2006;51:501–512
  18. Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology. 1999;53(suppl):1–6
  19. Tiwari A. Tamsulosin and floppy iris syndrome in benign prostatic hyperplasia patients. Expert Opin Investig Drugs. 2006;15:443–446
  20. Roehrborn CG, Schwinn DA. α1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol. 2004;171:1029–1035
  21. Michel MC, Okutsu H, Noguchi Y, et al. In vivo studies on the effects of α1-adrenoreceptor antagonists on pupil diameter and urethral tone in rabbits. Naunyn Schmiedebergs Arch Pharmacol. 2006;372:346–353
  22. Foglar R, Shibata K, Horie K, et al. Use of recombinant α1-adrenoreceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol. 1995;288:201–207
  23. Osher RH. Association between IFIS and flomax. [letter] J Cataract Refract Surg. 2006;32:547
  24. Bendel RE, Phillips MB. Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. J Cataract Refract Surg. 2006;32:1603–1605
  25. Gurbaxani A, Packard R. Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye. 2005;21:331–332
  26. Arshinoff SA. Modified SST-USST for tamsulosin-associated intraocular floppy-iris syndrome. J Cataract Refract Surg. 2006;32:559–561
  27. Chapple CR. A comparison of varying α-blockers and other pharmacotherapy options for lower urinary tract symptoms. Rev Urol. 2005;7(suppl 4):S22–S30

 No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(07)00620-7

doi: 10.1016/j.jcrs.2007.03.032

Journal of Cataract & Refractive Surgery
Volume 33, Issue 7 , Pages 1227-1234 , July 2007

Article Tools